CRISPR Therapeutics AG
F:1CG
CRISPR Therapeutics AG
F:1CG
Price:
50
EUR
13.64%
Market Closed
Market Cap:
€3.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CRISPR Therapeutics AG
F:1CG
|
CH |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
M
|
Marchex Inc
F:NHM
|
US |
|
Rexel SA
F:E7V0
|
FR |
|
A
|
Atrys Health SA
MAD:ATRY
|
ES |
|
Top Glove Corporation Bhd
SGX:BVA
|
MY |
|
GlobalData PLC
F:YK6
|
UK |
|
Z
|
Zee Media Corporation Ltd
BSE:532794
|
IN |
|
MorphoSys AG
F:MOR
|
DE |
|
C
|
Crealogix Holding AG
XMUN:CX1
|
CH |
|
CVR Energy Inc
F:FL9
|
US |
|
ESR-Logos REIT
F:UZ0
|
SG |
|
N
|
Nine Entertainment Co Holdings Ltd
OTC:NNMTF
|
AU |
|
M
|
Mallcom (India) Ltd
BSE:539400
|
IN |
|
M
|
Metacon AB (publ)
F:M16
|
SE |
|
P
|
PPL Corp
XMUN:PP9
|
US |
|
Aker Carbon Capture ASA
F:606
|
NO |
|
E
|
Element79 Gold Corp
CNSX:ELEM
|
CA |
|
Super Retail Group Ltd
F:RSU
|
AU |
|
C
|
Centamin PLC
XBER:7CT
|
JE |
|
M
|
Mastercraft Boat Holdings Inc
F:1SG
|
US |
Wall St Price Targets
1CG Price Targets Summary
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Wall Street analysts forecast 1CG stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1CG is 89.16 EUR with a low forecast of 36.28 EUR and a high forecast of 332.56 EUR.
Lowest Forecast
Price Target
36.28
EUR
27% Downside
Average Forecast
Price Target
89.16
EUR
78% Upside
Highest Forecast
Price Target
332.56
EUR
565% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1CG's stock price target?
Price Target
89.16
EUR
89.16
EUR
According to Wall Street analysts, the average 1-year price target for 1CG is 89.16 EUR with a low forecast of 36.28 EUR and a high forecast of 332.56 EUR.
What is the Revenue forecast for CRISPR Therapeutics AG?
Projected CAGR
119%
119%
Over the last 10 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 8 years is 119%.
